David S. Sanford

Oncology
1515 Holcombe Blvd Bldg 3RD
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions.

Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions.

Journal: Current oncology (Toronto, Ont.)
Published: May 13, 2026

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Journal: Current oncology (Toronto, Ont.)
Published: May 07, 2026

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Journal: Current oncology (Toronto, Ont.)
Published: May 07, 2026

Determinants of clinical trial participation in multiple myeloma: A population-based cohort study from British Columbia.

Determinants of clinical trial participation in multiple myeloma: A population-based cohort study from British Columbia.

Journal: Leukemia research
Published: April 30, 2026

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis.

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis.

Journal: British journal of haematology
Published: August 28, 2025

Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience.

Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience.

Journal: Stem cell reviews and reports
Published: May 17, 2025

Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes.

Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes.

Journal: Blood neoplasia
Published: May 06, 2025

Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years.

Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 Years.

Journal: Blood cell therapy
Published: January 29, 2025

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.

Journal: Annals of hematology
Published: August 14, 2024

Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival.

Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival.

Journal: Acta haematologica
Published: May 03, 2024

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.

CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.

Journal: Cancers
Published: January 05, 2024

Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.

Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.

Journal: Cytotherapy
Published: November 17, 2023
Showing 1-12 of 42

Last Updated: 09/26/2026